WHO ICTRP trial
Sitagliptin Acute Coronary Syndrome Randomised Investigation Registry
JPRN-UMIN000007340 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000007340 |
|---|---|
| Public title | Sitagliptin Acute Coronary Syndrome Randomised Investigation Registry |
| Scientific title | Sitagliptin Acute Coronary Syndrome Randomised Investigation Registry - SAMURAI-REGISTRY |
| Primary sponsor | Association of Kansai Cardiovascular Treatment Study |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | acute coronary syndrome requiring coronary stent implantation in patients with type 2 diabetes |
| Interventions | For Type 2 diabetic patients (HbA1c level: 6.5%-9.0%) with acute coronary syndrome, who had undergone coronary intervention with bare metal stent (Liberte; Coronary Stent System), Sitagliptin Phosphate Hydrate (DPP-4 Inhibitor) is initiated… |
| Registration date | Feb 24, 2012 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: